The information and opinions provided by speakers as well as Sino Biological employees during hosted webinar series are solely of their own and Sino Biological assumes no responsibility or liability for this content.
The information and opinions provided by speakers as well as Sino Biological employees during hosted webinar series are solely of their own and Sino Biological assumes no responsibility or liability for this content.
Hosted by Sino BiologicalMarch 25, 2021, 2PM, ESTSAXS-enabled Studies of mAbs Improve Detection of SARS-CoV-2 Nucleocapsid Protein & Reveal Conformational Plasticity-dependent Potency Changes
![]() |
Michal Hammel, Ph.D. |
• Research Scientist at Lawrence Berkeley National Laboratory • Founder of SAXS Consulting, Inc |
![]() |
Curtis D. Hodge, Ph.D. |
• Postdoctoral Fellow at Lawrence Berkeley National Laboratory • Co-Founder & CEO of Nanotein Technologies, Inc. |
Hosted by Sino BiologicalFebruary 26, 2021, 2PM, ESTCharacterization and Selection of Antibodies for COVID-19 Diagnostics Using Surface Plasmon Resonance (SPR)
![]() |
Michael Piazza, Ph.D. |
Systems Integration Manager, Nicoya |
![]() |
Soleil Grisé |
Senior Product Manager, Nicoya |
![]() |
Rob Burgess, Ph.D. |
Chief Business Officer, Sino Biological |
![]() |
Versatility & Flexibility: How the robustness and sensitivity of SPR makes it ideal for a wide range of biomolecular applications |
![]() |
Comprehensive Workflows: The benefits of SPR-based characterization studies for accelerating lead time on novel COVID-19 solutions |
![]() |
Maximizing Performance: How to develop a highly selective and specific antibody pair with SPR to optimize COVID-19 antigen detection |
![]() |
Looking Ahead: The next generation of SPR platforms advancing label-free detection to address the unmet needs of infectious disease research |
Cell Press Webinar | Sponsored by Sino BiologicalAugust 4, 2020 12 PM ETTherapies and Vaccine Development for Emerging and Re-emerging Diseases
August 18, 2020Bioactivity Evaluation of Neutralizing Antibodies In Vitro
August 27, 2020 7 AM PT Atlas of the SARS-CoV-2 Proteome
August 14, 2020 11 AM ET A Ticking Time Bomb: Tracing the Origin and Spread of SARS-CoV-2
July 28, 2020 2:30 PM ETPutting the Brakes on SARS-CoV-2: Neutralizing Antibodies
June 17, 2020 2:30 PM ETComprehending a Pandemic: SARS-CoV-2 Uncovered
July 21, 2020 | 2 p.m. ESTAdarza BiosystemsAnalyzing the Human Antibody Response to Pandemic Respiratory Viruses with Adarza's New ZIVA™ Platform and High Definition Antigen Arrays: A Case Study on COVID-19
July 23, 2020 | 2 p.m. ESTQuanterix | Institut PasteurCytokine Biomarkers of Inflammatory Response in COVID-19 Patients
July 28, 2020 | 2 p.m. ESTGyros Protein TechnologiesMicrofluidic, Nanoliter-scale Immunoassays for Rapid SARS-CoV-2 Antibody Analysis in Serology Testing, and Vaccine and Biotherapeutics Development
July 30, 2020 | 2 p.m. ESTUniversity of MichiganRapid and Quantitative Detection of SARS-CoV-2 Specific IgG for Convalescent Plasma Therapy
August 4, 2020 | 2 p.m. ESTE25BioFrequency of Direct Antigen Rapid Testing for COVID-19 Reduces Transmission
August 6, 2020 | 2 p.m. ESTNirmidas Biotech | Stanford UniversityHigh-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform
August 13, 2020 | 2 p.m. ESTGator BioNext Generation BLI: Novel Applications in the Fight against COVID-19
1pm EST, June 30, 2020 Engineering Optimized Anti-SARS-CoV-2 Antibody Therapeutics
1pm EST, May 27, 2020Multiplex Serological Assays for COVID-19
2:30pm, May 21, 2020SARS-CoV-2 (COVID-19) Vaccine Development
The 4th presentation of the WVC Covid-19 Webinar Series was sponsored by Sino Biological. This webinar was moderated by Dr. Philip Krause, Deputy Director, OVRR, CBER, FDA.
Speaker: Dr. Kate Broderick, SVP R&D Preclinical, Inovio
Subject: Advantages of DNA vaccines in response to COVID-19 and Inovio's progress
Time: 11am, May 12th, 2020
The COVID-19 pandemic has a significant impact on nearly every aspect of ordinary life worldwide. There is an urgent need to establish tool sets to facilitate the generation of therapeutic agents as well as vaccines. In this webinar, Sino Biological focused on the design, strategy, process, and troubleshooting in generating high-quality viral proteins via recombinant protein expression technologies as well as the multi-strategic effort for generating anti-viral antibodies for serological diagnostic applications.
In this complimentary guide, specific case studies will be conducted on the problems encountered in the development of recombinant proteins in several common expression systems, including expression host choice, vectors, expression fragments, culture condition and purification, etc.
Download the guide to learn:
1. Recombinant Protein Expression Overview
2. Key Influencing Factors for Protein Expression
3. FAQs & Case Studies
In this guide, you can learn the technical information about antibody development, from immunization, technology platform selection, antibody screening to quality validation, and an in-depth overview of featured technology platforms for monoclonal antibody development, including traditional hybridoma technology and phage display based on recombinant method.
Download the free guide to learn:
1. Antibody Development Introduction
2. Antibody Application Validation
3. How to Choose a Proper Antibody Reagent
FREE guide about all details of mAb generation platforms shared by Sino Biological.
Download this FREE Guide to Learn:
Principles, Processes, Case Studies, and Pros & Cons of the Following MAb Generation Platforms:
Hybridoma Technology
Immunized Phage Display Antibody Library
Human Naïve Antibody Library
Single B Cell Antibody Technology
This guide covers general principles and all the key points about how to optimize a FCM experiment, from experimental design, sample preparation, fluorescence staining, detection to data analysis.
Download this FREE Guide to Learn:
• Introduction to Flow Cytometry
• Principle of Flow Cytometer
• Tips & Tricks for Flow Cytometry
• Flow Cytometry Troubleshooting
• Applications in Cancer Research
Sino Biological take a part in Coronavirus Virtual Event on 2nd Apr,2020. We have shared a lot with customers about Sino Biological's effort on Serological Study of COVID-19.